International Companies

Novo Nordisk surges as Hims & Hers ditches copycat weight-loss pill

By Michele Maatouk

Date: Monday 09 Feb 2026

(Sharecast News) - Shares of Danish pharmaceuticals firm Novo Nordisk surged on Monday after US telehealth company Hims & Hers said it had ditched plans to sell its own version of the Wegovy weight-loss drug.
On a post on X on Saturday, the company said: "Since launching the compounded semaglutide pill...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page